Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,813 | 16,763 | 19,371 | 18,225 | 12,485 |
| Marketable Securities | N/A | N/A | 2,496 | 7,987 | 13,969 |
| Other current assets | 68 | 135 | 0 | 0 | 0 |
| TOTAL | $11,495 | $17,933 | $23,236 | $27,083 | $27,511 |
| Non-Current Assets | |||||
| PPE Net | 83 | 105 | 263 | 200 | 219 |
| Other Non-Current Assets | 22 | 22 | 22 | 122 | 122 |
| TOTAL | $105 | $127 | $285 | $322 | $341 |
| Total Assets | $11,600 | $18,060 | $23,521 | $27,405 | $27,852 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60 | 1,676 | 441 | 385 | 431 |
| Accrued Expenses | 1,995 | 1,559 | 2,637 | 2,149 | 1,800 |
| TOTAL | $2,123 | $3,370 | $3,078 | $2,534 | $2,231 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,123 | $3,370 | $3,078 | $2,534 | $2,231 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 490 | 490 | 481 | 481 | 443 |
| Common Shares | 19 | 19 | N/A | 19 | 18 |
| Retained earnings | -222,316 | -217,001 | -210,470 | -205,211 | -200,701 |
| Other shareholders' equity | 21,187 | 21,186 | 21,528 | 21,527 | 21,524 |
| TOTAL | $9,477 | $14,690 | $20,443 | $24,871 | $25,621 |
| Total Liabilities And Equity | $11,600 | $18,060 | $23,521 | $27,405 | $27,852 |